Human gene editing therapies are OK in certain cases, panel advises

Expert group recommends long-term tracking, other restrictions for germline tinkering

bubble boy

EDITING OUT DISEASE  Gene therapy can cure a genetic disease called severe combined immunodeficiency, or “bubble boy,” disease. Using new gene editing techniques like CRISPR/Cas9 to treat genetic diseases is fine under certain conditions, but it should not be used to enhance people, a panel of experts says.

LAURENT/BSIP SA/Alamy Stock Photo

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Genetics

From the Nature Index

Paid Content